Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.3.2 and no longer shows Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now displays a new revision label: Revision: v3.3.1, and the previous label Revision: v3.2.0 has been removed. This is a minor update to the page's version information and does not alter study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedDeletion of the banner about government funding lapses and NIH operating status, which does not affect the study details or core information for NCT03347123. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedNo meaningful changes were observed in the study record; the page content and eligibility details remain the same.SummaryDifference0.4%

- Check63 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check71 days agoChange DetectedUpdated medical naming to a more specific form and bumped the revision version from v3.0.2 to v3.1.0.SummaryDifference0.5%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.